Laura San‐Segundo

1.6k total citations
44 papers, 1.0k citations indexed

About

Laura San‐Segundo is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Laura San‐Segundo has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 27 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Laura San‐Segundo's work include Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (10 papers) and Histone Deacetylase Inhibitors Research (6 papers). Laura San‐Segundo is often cited by papers focused on Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (10 papers) and Histone Deacetylase Inhibitors Research (6 papers). Laura San‐Segundo collaborates with scholars based in Spain, United States and United Kingdom. Laura San‐Segundo's co-authors include Enrique M. Ocio, Mercedes Garayoa, Jesús F. San Miguel, Luís A. Corchete, Norma C. Gutiérrez, Teresa Paíno, Atanasio Pandiella, María‐Victoria Mateos, Enrique de Álava and Carlos Fernández and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Laura San‐Segundo

44 papers receiving 1.0k citations

Peers

Countries citing papers authored by Laura San‐Segundo

Since Specialization

Citations

This map shows the geographic impact of Laura San‐Segundo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura San‐Segundo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura San‐Segundo more than expected).

Fields of papers citing papers by Laura San‐Segundo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura San‐Segundo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura San‐Segundo. The network helps show where Laura San‐Segundo may publish in the future.

Co-authorship network of co-authors of Laura San‐Segundo

This figure shows the co-authorship network connecting the top 25 collaborators of Laura San‐Segundo. A scholar is included among the top collaborators of Laura San‐Segundo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura San‐Segundo. Laura San‐Segundo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Laura San‐Segundo, Jesús Pérez‐Losada, Rogelio González‐Sarmiento, Ana B. Herrero	8
2	Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease 2021 ·Nature Communications ·Antonio García-Gómez, Tianlu Li, Carlos de la Calle‐Fabregat, Javier Rodríguez‐Ubreva, Laura Ciudad, Francesc Català‐Moll, (unknown), (unknown), Laura San‐Segundo, Sandra Muntión, Xabier Morales, Carlos Ortíz-de-Solórzano, Julen Oyarzábal, Edurne San José‐Eneriz, Manel Esteller, Xabier Agirre, Felipe Prósper, Mercedes Garayoa, Esteban Ballestar	35
3	Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies) 2020 ·Annals of Hematology ·Elena Bussaglia, Marta Pratcorona, (unknown), Laura San‐Segundo, Miguel A. Rubio, (unknown), (unknown), Isabel Badell, Jordi Esteve, Montserrat Arnán, Carme Talarn, Mar Tormo, (unknown), Ferran Vall‐Llovera, Xavier Ortı́n, Carme Pedro, Joan Bargay, Salut Brunet, Jorge Sierra, Josep Nomdedéu	5
4	CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition 2020 ·Leukemia ·Miguel Quijada‐Álamo, María Hernández‐Sánchez, (unknown), Ana E. Rodríguez‐Vicente, Ignacio García‐Tuñón, (unknown), Jesús María Hernández-Sánchez, Ana B. Herrero, José María Bastida, Laura San‐Segundo, Michaela Gruber, Juan Luis Garcı́a, Shanye Yin, Elisa ten Hacken, Rocío Benito, José Luis Ordóñez, Catherine J. Wu, Jesús María Hernández‐Rivas	25
5	Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma 2020 ·Cancers ·Teresa Paíno, (unknown), Laura San‐Segundo, Luís A. Corchete, Susana Hernández-García, (unknown), (unknown), (unknown), (unknown), Norma C. Gutiérrez, María‐Victoria Mateos, Mercedes Garayoa, Enrique M. Ocio	10
6	Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma 2019 ·Haematologica ·(unknown), (unknown), (unknown), Susana Hernández-García, Luís A. Corchete, Laura San‐Segundo, (unknown), (unknown), Marie Schoumacher, Sébastien Banquet, Laurence Kraus‐Berthier, Ioana Kloos, (unknown), Ensar Halilovic, Heiko Maacke, Norma C. Gutiérrez, María‐Victoria Mateos, Teresa Paíno, Mercedes Garayoa, Enrique M. Ocio	42
7	Amiloride, An Old Diuretic Drug, Is a Potential Therapeutic Agent for Multiple Myeloma 2017 ·Clinical Cancer Research ·Elizabeta A. Rojas, Luís A. Corchete, Laura San‐Segundo, Juan F. Martínez‐Blanch, Francisco M. Codoñer, Teresa Paíno, Noemí Puig, Ramón García‐Sánz, María‐Victoria Mateos, Enrique M. Ocio, Irena Misiewicz-Krzemińska, Norma C. Gutiérrez	28
8	The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma 2017 ·Haematologica ·Susana Hernández-García, Laura San‐Segundo, (unknown), Luís A. Corchete, Irena Misiewicz-Krzemińska, (unknown), (unknown), (unknown), (unknown), (unknown), Teresa Paíno, Brian Tunquist, María‐Victoria Mateos, Norma C. Gutiérrez, Elena Díaz‐Rodríguez, Mercedes Garayoa, Enrique M. Ocio	21
9	The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care 2016 ·Clinical Cancer Research ·Teresa Paíno, Antonio García-Gómez, (unknown), Laura San‐Segundo, Susana Hernández-García, (unknown), (unknown), (unknown), (unknown), Carlos Ortíz-de-Solórzano, Luís A. Corchete, Norma C. Gutiérrez, (unknown), Mercedes Garayoa, Enrique M. Ocio	43
10	Alterations in gene expression levels provide early indicators of chemical stress during Xenopus laevis embryo development: A case study with perfluorooctane sulfonate (PFOS) 2016 ·Ecotoxicology and Environmental Safety ·Laura San‐Segundo, Laura Guimarães, Carlos Fernández, Eulalia María Beltrán, Lúcia Guilhermino, María Victoria Pablos	18
11	Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development 2016 ·Journal of Hematology & Oncology ·(unknown), (unknown), Júlia Almeida, Laura San‐Segundo, Susana Inogés, Ángel Santos‐Briz, Jesús G. Briñón, Luís A. Corchete, Jesús F. San Miguel, Consuelo del Cañizo, Belén Blanco	81
12	PTPN13 and β-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche 2015 ·Stem Cell Reports ·Guillermo López-Ruano, (unknown), Teresa Lopes Ramos, Laura San‐Segundo, Luis Ignacio Sánchez‐Abarca, Fermín Sánchez‐Guijo, Josè Antonio Pérez-Simón, Jesús Sánchez‐Yagüe, Marcial Llanillo, Ángel Hernández‐Hernández	12
13	Stage-dependent ethoxyresorufin-O-deethylase (EROD) in vivo activity in medaka (Oryzias latipes) embryos 2015 ·Chemosphere ·Miguel González-Doncel, G. Carbonell, Laura San‐Segundo, (unknown), Eulalia María Beltrán, Carlos Fernández	7
14	In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone 2014 ·Leukemia ·Enrique M. Ocio, Diego Fernández‐Lázaro, Laura San‐Segundo, Lucía López‐Corral, Luís A. Corchete, Norma C. Gutiérrez, Mercedes Garayoa, Teresa Paíno, Antonio García-Gómez, María del Mar Delgado, Juan Carlos Montero, Elena Díaz‐Rodríguez, María‐Victoria Mateos, Atanasio Pandiella, Suzana S. Couto, (unknown), Chad C. Bjorklund, Jesús F. San Miguel	58
15	Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138++ and CD138low Subpopulations in Multiple Myeloma Cell Lines 2014 ·PLoS ONE ·Teresa Paíno, María Eugenia Sarasquete, Bruno Paiva, Patryk Krzemiński, Laura San‐Segundo, Luís A. Corchete, Alba Redondo, Mercedes Garayoa, Ramón García‐Sánz, Norma C. Gutiérrez, Enrique M. Ocio, Jesús F. San Miguel	20
16	Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile 2013 ·Blood ·Bruno Paiva, Teresa Paíno, (unknown), Mercedes Garayoa, Laura San‐Segundo, (unknown), Inês Mota, (unknown), Paloma Bárcena, Irene Aires‐Mejía, Luís A. Corchete, Cristina Jiménez, Ramón García‐Sánz, Norma C. Gutiérrez, Enrique M. Ocio, María‐Victoria Mateos, María‐Belén Vídriales, Alberto Órfão, Jesús F. San Miguel	115
17	Embryonic exposure of medaka (Oryzias latipes) to propylparaben: Effects on early development and post-hatching growth 2013 ·Environmental Pollution ·Miguel González-Doncel, (unknown), Laura San‐Segundo, Eulalia María Beltrán, (unknown), Carlos Fernández	31
18	CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype 2012 ·Haematologica ·Teresa Paíno, Enrique M. Ocio, Bruno Paiva, Laura San‐Segundo, Mercedes Garayoa, Norma C. Gutiérrez, María Eugenia Sarasquete, Atanasio Pandiella, Alberto Orfao, Jesús F. San Miguel	26
19	Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma 2011 ·Annals of Hematology ·Edvan de Queiroz Crusoé, Patricia Maiso, Diego Fernández‐Lázaro, Laura San‐Segundo, Mercedes Garayoa, Antonio García-Gómez, Norma C. Gutiérrez, (unknown), Enrique Colado, Jesús Martín, Francis Y. Lee, Enrique M. Ocio	4
20	Dynamics of BNF-induced in vivo ethoxyresorufin-O-deethylase (EROD) activity during embryonic development of medaka (Oryzias latipes) 2011 ·Aquatic Toxicology ·Miguel González-Doncel, Laura San‐Segundo, (unknown), José Tarazona, Carlos Fernández	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact